Can the HIV-1 splicing machinery be targeted for drug discovery?

References

• HryckiewiczKBuraMKowala-PiaskowskaABolewskaBMozer-LisewskaIHIV RNA splicingHIV AIDS Rev20111036164
   Google Scholar
• OcwiejaKESherrill-MixSMukherjeeRDynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencingNucleic Acids Res20124020103451035522923523
   PubMed Web of Science ®Google Scholar
• KarnJStoltzfusCMTranscriptional and posttranscriptional regulation of HIV-1 gene expressionCold Spring Harb Perspect Med201222a00691622355797
   PubMed Web of Science ®Google Scholar
• BohneJWodrichHKrãusslichH-GSplicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5′ endNucleic Acids Res200533382583715701754
   PubMed Web of Science ®Google Scholar
• StoltzfusCMChapter 1 Regulation of HIV-1 Alternative RNA Splicing and Its Role in Virus ReplicationAdv Virus Res20097414019698894
   PubMed Web of Science ®Google Scholar
• PurcellDFMartinMAAlternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivityJ Virol19936711636563788411338
   PubMed Web of Science ®Google Scholar
• O’ReillyMMMcNallyMTBeemonKLTwo strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNAVirology199521323733857491762
   PubMed Web of Science ®Google Scholar
• SiZ-hRauchDStoltzfusCMThe exon splicing silencer in human immunodeficiency virus type 1 tat exon 3 is bipartite and acts early in spliceosome assemblyMol Cell Biol1998189540454139710624
   PubMed Web of Science ®Google Scholar
• KammlerSOtteMHauberIKjemsJHauberJSchaalHThe strength of the HIV-1 3′ splice sites affects REV functionRetrovirology200638917144911
   PubMed Web of Science ®Google Scholar
• TaziJBakkourNMarchandVYadiLAboufirassiABranlaniCAlternative splicing: regulation of HIV-1 replication as a target for therapeutic actionFEBS J201027786787620082634
   PubMed Web of Science ®Google Scholar
• ManleyJLKrainerARA rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)Genes Dev201024111073107420516191
   PubMed Web of Science ®Google Scholar
• GraveleyBRSorting out the complexity of SR protein functionsRNA2000691197121110999598
   PubMed Web of Science ®Google Scholar
• MermoudJECohenPLamondAISer/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicingNucleic Acids Res19922020526352691331983
   PubMed Web of Science ®Google Scholar
• ExlineCMFengZStoltzfusCMNegative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expressionJ Virol20088283921393118272582
   PubMed Web of Science ®Google Scholar
• TranellAFenyoEMSchwartzSSerine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5′-splice site of exon 3J Biol Chem201028541315373154720685659
   PubMed Web of Science ®Google Scholar
• RopersDAyadiLGattoniRDifferential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNAJ Biol Chem200427929299632997315123677
   PubMed Web of Science ®Google Scholar
• TranellATingsborgSFenyãEMSchwartzSInhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasmVirus Res20111571829121345357
   PubMed Web of Science ®Google Scholar
• CaputiMMayedaAKrainerARZahlerAMhnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicingEMBO J199918144060406710406810
   PubMed Web of Science ®Google Scholar
• Jean-PhilippeJPazSMichaelLLu, Caputi M. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replicationBiochim Biophys Acta20141839425125824530421
   PubMed Web of Science ®Google Scholar
• JacquenetSMãreauAsBilodeauPSDamierLStoltzfusCMBranlantCA second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of tat mRNA and binds protein hnRNP HJ Biol Chem200127644404644047511526107
   PubMed Web of Science ®Google Scholar
• ZahlerAMDamgaardCKKjemsJCaputiMSC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicingJ Biol Chem200427911100771008414703516
   PubMed Web of Science ®Google Scholar
• DomsicJKWangYMayedaAKrainerARStoltzfusCMHuman immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tractsMol Cell Biol200323238762877214612416
   PubMed Web of Science ®Google Scholar
• AmendtBASiZHStoltzfusCMPresence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factorsMol Cell Biol1995158460646157623852
   PubMed Web of Science ®Google Scholar
• JeangK-TMulti-faceted post-transcriptional functions of HIV-1 RevBiology20121216517424832222
   PubMedGoogle Scholar
• SchaubMCLopezSRCaputiMMembers of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexesJ Biol Chem200728218136171362617337441
   PubMed Web of Science ®Google Scholar
• MuellerNvan BelNBerkhoutBDasATHIV-1 splicing at the major splice donor site is restricted by RNA structureVirology2014468–470609620
   Web of Science ®Google Scholar
• LevengoodJDRollinsCMishlerCHJSolution structure of the HIV-1 exon splicing silencer 3J Mol Biol201241568069822154809
   PubMed Web of Science ®Google Scholar
• ShunaevaAPotashnikovaDPichuginAImprovement of HIV-1 and human T cell lymphotropic virus type 1 replication-dependent vectors via optimization of reporter gene reconstitution and modification with intronic short hairpin RNAJ Virol2015892010591160126269177
   PubMed Web of Science ®Google Scholar
• KennedyEMBogerdHPKornepatiAVPosttranscriptional m(6) A editing of HIV-1 mRNAs enhances viral gene expressionCell Host Microbe201619567568527117054
   PubMed Web of Science ®Google Scholar
• LichinchiGGaoSSaletoreYDynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cellsNat Microbiol201611601127572442
   PubMed Web of Science ®Google Scholar
• ChangDDSharpPAMessenger RNA transport and HIV rev regulationScience199024949696146152143313
   PubMed Web of Science ®Google Scholar
• PollardVWMalimMHThe HIV-1 REV proteinAnn Rev Microbiol19985214915329891806
   PubMed Web of Science ®Google Scholar
• StrebelKVirus-host interactions: role of HIV proteins Vif, Tat, and RevAids200317Suppl 4S25S3415080177
   PubMedGoogle Scholar
• BevecDJakscheHOftMInhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5AScience19962715257185818608596953
   PubMed Web of Science ®Google Scholar
• KulaAMarcelloADynamic post-transcriptional regulation of HIV-1 gene expressionBiology2012111613324832221
   PubMedGoogle Scholar
• GrafMBojakADemlLBielerKWolfHWagnerRConcerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expressionJ Virol20007422108221082611044131
   PubMed Web of Science ®Google Scholar
• SodroskiJRosenCGohWCHaseltineWA transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virusScience19852284706143014342990028
   PubMed Web of Science ®Google Scholar
• BieniaszPDGrdinaTABogerdHPCullenBRRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcriptionProc Natl Acad Sci US A1999961477917796
   PubMed Web of Science ®Google Scholar
• BerroRKehnKde la FuenteCAcetylated tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32J Virol20068073189320416537587
   PubMed Web of Science ®Google Scholar
• JablonskiJAAmelioALGiaccaMCaputiMThe transcriptional transactivator Tat selectively regulates viral splicingNucleic Acids Res20103841249126019966273
   PubMed Web of Science ®Google Scholar
• HashizumeCKuramitsuMZhangXKurosawaTKamataMAidaYHuman immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibitionMicrobes Infect20079449049717347016
   PubMed Web of Science ®Google Scholar
• TeradaYYasudaYHuman immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145Molecular and cellular biology200626218149815816923959
   PubMed Web of Science ®Google Scholar
• BaeyensANaessensEVan NuffelAHIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genomeSci Rep201663457327721439
   PubMed Web of Science ®Google Scholar
• BrosseauJPLucierJFLamarcheAARedirecting splicing with bifunctional oligonucleotidesNucleic Acids Res2014426e4024375754
   PubMed Web of Science ®Google Scholar
• WangGZhaoNBerkhoutBDasATCRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escapeMol Ther201624352252626796669
   PubMed Web of Science ®Google Scholar
• BakkourNLinY-LMaireSSmall-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistancePLoS Pathog2007310e159
   Web of Science ®Google Scholar
• OheKHagiwaraMModulation of alternative splicing with chemical compounds in new therapeutics for human diseasesACS Chem Biol201510491492425560473
   PubMed Web of Science ®Google Scholar
• CheungPKHorhantDBandyLEA parallel synthesis approach to the identification of novel diheteroarylamide-based compounds blocking HIV replication: potential inhibitors of HIV-1 Pre-mRNA alternative splicingJ Med Chem20165951869187926878150
   PubMed Web of Science ®Google Scholar
• PradoSBeltranMCoirasMBedoyaLMAlcamiJGallegoJBioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screenBiochem Pharmacol2016107142826896646
   PubMed Web of Science ®Google Scholar
• WongRBalachandranAHaalandMStoilovPCochraneAHIV-1 RNA processing as therapeutic target: characterization of small molecule modulators of HIV-1 RNA processing and transportRetrovirology2013101O45
   Google Scholar
• NiedzielskiMFHopewellRIsmailZEstableMCMCEF is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses HIV-1 Tat-transactivation of LTR-directed transcriptionInt J Biol Sci20073422523617389929
   PubMed Web of Science ®Google Scholar
• D’OrsoIGrunwellJRNakamuraRLDasCFrankelADTargeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexesJ Virol200882199492950418667497
   PubMed Web of Science ®Google Scholar
• PazSKrainerARCaputiMHIV-1 transcription is regulated by splicing factor SRSF1Nucleic Acids Res20144222138121382325416801
   PubMed Web of Science ®Google Scholar
• HwangSTamilarasuNRyanKInhibition of gene expression in human cells through small molecule-RNA interactionsProc Natl Acad Sci U S A19999623129971300210557261
   PubMed Web of Science ®Google Scholar
• WongRWBalachandranAHaalandMStoilovPCochraneACharacterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev functionNucleic Acids Res201341209471948323945945
   PubMed Web of Science ®Google Scholar